Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure

被引:4
|
作者
Wozny, Lukasz [1 ]
Zywiec, Joanna [1 ]
Gosek, Katarzyna [1 ]
Kuzniewicz, Roman [1 ]
Gorczynska-Kosiorz, Sylwia [1 ]
Trautsolt, Wanda [1 ]
snit, Miroslaw [1 ]
Grzeszczak, Wladyslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci Zabrze, Dept Internal Med Diabetol & Nephrol, PL-40055 Katowice, Poland
关键词
fractalkine; fractalkine receptor; inflammation; end-stage renal disease;
D O I
10.3390/ijerph18042202
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Fractalkine (CX3CL1) is a chemokine that plays a significant role in inflammation, one of the pathophysiological processes underlying end-stage renal disease (ESRD). Genetic factors are significantly involved in cytokine expression and have been studied as potential risk factors for chronic kidney disease (CKD). Objectives: We aimed to elucidate the association of CX3CR1 gene polymorphisms rs3732378 and rs3732379 with the levels of CX3CL1, CX3CL1 receptor (CX3CR1), as well as C-reactive protein (CRP). Patients and methods: We enrolled 198 participants, including 106 patients with ESRD and 92 controls. Peripheral blood samples were collected from each patient for genetic (rs3732378 and rs3732379 polymorphisms) and immunoenzymatic (fractalkine, CX3CR1, CRP) tests. Results: CX3CR1 and CRP levels were higher in patients with ESRD than in controls (p < 0.05). Fractalkine levels were significantly higher in ESRD patients who were homozygous for the G allele of the rs3732378 polymorphism and for the C allele of the rs3732379 polymorphism than in homozygous controls. Moreover, carriers of these alleles among patients with ESRD had significantly higher CX3CR1 levels than controls. Conclusions: The G allele of the rs3732378 polymorphism and the C allele of the rs3732379 polymorphism of the CX3CR1 gene are associated with higher CX3CL1 and CX3CR1 levels. Our study suggests that CX3CR1 gene polymorphisms could be potentially involved in the pathogenesis of ESRD, but the study needs to be replicated in a larger population with a longitudinal follow-up study. Identification of genetic factors associated with inflammation in ESRD may contribute to the development of targeted gene therapies in the future.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [41] Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis
    Fang, IM
    Lin, CP
    Yang, CM
    Chen, MS
    Yang, CH
    MOLECULAR VISION, 2005, 11 (52): : 443 - 451
  • [42] EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
    P Gazerani
    BE Cairns
    XD Dong
    The Journal of Headache and Pain, 2014, 15
  • [43] Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation
    Oh, In-Soo
    Suh, Dong-Whan
    Park, Sung-Ryeoll
    Ha, Kee-Yong
    INDIAN JOURNAL OF ORTHOPAEDICS, 2015, 49 (02) : 239 - 244
  • [44] Fractalkine and Its Receptor (CX3CR1) in Patients with Stable Coronary Artery Disease and Diabetes Mellitus
    Njerve, Ida Unhammer
    Pettersen, Alf Age
    Opstad, Trine Baur
    Arnesen, Harald
    Seljeflot, Ingebjorg
    METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (06) : 400 - 406
  • [45] Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update
    D'Haese, Jan G.
    Friess, Helmut
    Ceyhan, Gueralp O.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (06) : 613 - 618
  • [46] Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 -: Rapid communication
    Feng, LL
    Chen, SZ
    Garcia, GE
    Xia, YY
    Siani, MA
    Botti, P
    Wilson, CB
    Harrison, JK
    Bacon, KB
    KIDNEY INTERNATIONAL, 1999, 56 (02) : 612 - 620
  • [47] Role of fractalkine receptor (CX3CR1) in microglial mediated inflammation in the Diabetic Retina
    Mendiola, Andrew S.
    Cardona, Sandra M.
    Tsin, Andrew T. C.
    Cardona, Astrid E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
    Hosokawa, Y
    Nakanishi, T
    Yamaguchi, D
    Nakae, H
    Matsuo, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 506 - 512
  • [49] Fractalkine及其受体CX3CR1与冠心病
    陈章强
    金希
    国外医学(老年医学分册), 2003, (05) : 195 - 198
  • [50] Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure
    Koller, Lorenz
    Blum, Steffen
    Korpak, Magdalena
    Richter, Bernhard
    Goliasch, Georg
    Zorn, Gerlinde
    Brekalo, Mira
    Maurer, Gerald
    Wojta, Johann
    Pacher, Richard
    Huelsmann, Martin
    Niessner, Alexander
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (01) : 96 - 97